Can Rinvoq cause a pleural effusion?

Yes, Rinvoq (upadacitinib) can cause pleural effusion as one of the side effects. The description of the drug mentions pleural effusion and pleurisy as possible complications associated with the use of this drug.

Rinvoq is a Janus kinase (JAK) inhibitor and is used to treat a variety of inflammatory diseases, but it can increase the risk of pulmonary complications, including pleural effusion. If you experience shortness of breath or other respiratory symptoms during Rinvoq therapy, consult your doctor immediately.

If you need more personalized advice, you can use teleconsultations here:

https://www.gdziepolek.pl/telekonsultacja/

The advice is provided in Polish.